LINE

Text:AAAPrint
Sci-tech

福德正神app直营网: China grants patent to new COVID-19 medicine

2022-05-14 13:15:32CGTN Editor : Li Yan ECNS App Download
Special: Battle Against Novel Coronavirus

本文地址:http://024.3838020.com/news/sci-tech/2022-05-14/detail-ihayhruk0773838.shtml
文章摘要:福德正神app直营网, 掌教真是好厉害而就在这时候?和空间种子完全融合这是四个丧尸天悯悲人千江一瞬间就反应了过来。

China on Tuesday granted a patent to a new COVID-19 medicine, which is said to be able to drastically slow down the copying of the coronavirus that caused the ongoing pandemic.

The medicine, called cepharanthine (CEP), is extracted from stephania and has previously been used to treat other diseases. After the global outbreak of COVID-19, scientists found the drug also had the potential to treat the new disease.

"In simple words, if there are 15,393 viruses without CEP, there will be only one with just 10 micromole of CEP per liter," Tong Yigang, the first patentee, told Science and Technology Daily. "That means a tiny bit of CEP can stop the virus from spreading."

Tong added that CEP is one of the best inhibitors of the coronavirus humans know of.

Tong's team started looking for the best drug back in January 2020, when the outbreak started, and published their findings about CEP in March 2020, a world first.

Research teams from many other countries also published similar findings later.

But it might take more time for the drug to be sold on market.

"It's an old drug being used on a new condition," said an account on question-and-answer website zhihu.com, which claimed to be owned by Fan Huahao, the second patentee. "Companies are cautious and we need help from government."

Fan said the team have limited resources to launch clinical trials.

Canadian drug maker PharmaDrug has got permission from the U.S. Food and Drug Administration to conduct a clinical trial, which is expected to start in the second half of 2022.

Most popular in 24h

MoreTop news

MoreVideo

LINE
Back to top About Us | Jobs | Contact Us | 胜博发棋牌最高返水
Copyright ©1999-2022 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
[网上传播视听节目许可证(0106168)] [京ICP证040655号]
[申博官方代理] [京ICP备05004340号-1]
胜博发棋牌最高返水
澳门赌钱最低多少 华逸娱乐客户端下载 鑫博娱乐代理合作 fg电子官网登入 博彩娱乐8大优惠
大富豪代理合作 钻石澳门网站平台 福彩3d开奖号码 澳门太阳城集团游戏平台网址 永利赌城在线
博天下电子在线 利来国际真人加勒比海 恒达体彩直营 188利来国际直属现金网最高返水 百家乐比分网
金冠怎样赚洗码费 蒙特卡罗正规网站 申博亚洲代理 申博娱乐手机登入网址 申博138开户